Avidity acquisition news reveals the latest Phase 3 setback for Novartis’ dystrophy drug, raising concerns in the pharma industry.
pharma
FDA Approval for Modafinil: Safe and Proven Treatment
FDA approval for Modafinil marks a significant step in treatment options.